116 related articles for article (PubMed ID: 26181003)
1. Therapy for Hematologic Cancers in Older Patients, Quality of Life, and Health Economics: Difficult Decisions.
Deeg HJ; Steuten LM
JAMA Oncol; 2015 Aug; 1(5):571-2. PubMed ID: 26181003
[No Abstract] [Full Text] [Related]
2. Value of innovation for hematologic malignancies.
Monia M
J Med Econ; 2016; 19(5):487-9. PubMed ID: 26706602
[TBL] [Abstract][Full Text] [Related]
3. Treatment ethics, quality of life and health economics in the management of hematopoietic malignancies in older patients.
Deeg HJ
Bone Marrow Transplant; 2015 Sep; 50(9):1145-9. PubMed ID: 26052908
[TBL] [Abstract][Full Text] [Related]
4. Treating hematologic malignancies: barriers to care.
Shonkwiler E
ONS News; 2006; 21(8 Suppl):23-4. PubMed ID: 16925137
[No Abstract] [Full Text] [Related]
5. Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at increased surgical risk: results from the SAPPHIRE trial.
Mahoney EM; Greenberg D; Lavelle TA; Natarajan A; Berezin R; Ishak KJ; Caro JJ; Yadav JS; Gray WA; Wholey MH; Cohen DJ
Catheter Cardiovasc Interv; 2011 Mar; 77(4):463-72. PubMed ID: 21351220
[TBL] [Abstract][Full Text] [Related]
6. Aging diseases--do they prevent preventive health care from saving costs?
Gandjour A
Health Econ; 2009 Mar; 18(3):355-62. PubMed ID: 18833543
[TBL] [Abstract][Full Text] [Related]
7. Costs and cost-effectiveness of allogeneic stem cell transplantation in children are predictable.
Matthes-Martin S; Pötschger U; Barr R; Martin M; Boztug H; Klingebiel T; Attarbaschi A; Eibler W; Mann G
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1533-9. PubMed ID: 22484665
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis.
Simons CT; Cipriano LE; Shah RU; Garber AM; Owens DK; Hlatky MA
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):419-28. PubMed ID: 23838104
[TBL] [Abstract][Full Text] [Related]
9. Use of Global Visual Acuity Data in a time trade-off approach to calculate the cost utility of cataract surgery: methodological issues of cost-utility comparisons.
Frick KD; Massof RW
Arch Ophthalmol; 2009 Sep; 127(9):1205-6. PubMed ID: 19752432
[No Abstract] [Full Text] [Related]
10. A comparison of open and endovascular revascularization for chronic mesenteric ischemia in a clinical decision model.
Hogendoorn W; Hunink MG; Schlösser FJ; Moll FL; Muhs BE; Sumpio BE
J Vasc Surg; 2014 Sep; 60(3):715-25.e2. PubMed ID: 24721175
[TBL] [Abstract][Full Text] [Related]
11. Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German setting.
Blohmer JU; Rezai M; Kümmel S; Kühn T; Warm M; Friedrichs K; Benkow A; Valentine WJ; Eiermann W
J Med Econ; 2013; 16(1):30-40. PubMed ID: 22966753
[TBL] [Abstract][Full Text] [Related]
12. How should we assess the value of innovative drugs in oncology? Lessons from cost-effectiveness analyses.
Prasad V; Mailankody S
Blood; 2015 Oct; 126(15):1860-1. PubMed ID: 26320099
[No Abstract] [Full Text] [Related]
13. What do haematological cancer survivors want help with? A cross-sectional investigation of unmet supportive care needs.
Hall AE; Sanson-Fisher RW; Lynagh MC; Tzelepis F; D'Este C
BMC Res Notes; 2015 Jun; 8():221. PubMed ID: 26047620
[TBL] [Abstract][Full Text] [Related]
14. Assessing the economic value of anticancer therapies.
Neymark N
Recent Results Cancer Res; 1998; 148():1-285. PubMed ID: 9670279
[No Abstract] [Full Text] [Related]
15. Use of Global Visual Acuity Data in a time trade-off approach to calculate the cost utility of cataract surgery.
Lansingh VC; Carter MJ
Arch Ophthalmol; 2009 Sep; 127(9):1183-93. PubMed ID: 19752429
[TBL] [Abstract][Full Text] [Related]
16. The use of quality-adjusted life years (QALYs) in the economic appraisal of health care.
Kawachi I; Bethwaite P; Bethwaite J
N Z Med J; 1990 Feb; 103(883):46-8. PubMed ID: 2106105
[No Abstract] [Full Text] [Related]
17. Expanding the criteria for BRCA mutation testing in breast cancer survivors.
Kwon JS; Gutierrez-Barrera AM; Young D; Sun CC; Daniels MS; Lu KH; Arun B
J Clin Oncol; 2010 Sep; 28(27):4214-20. PubMed ID: 20733129
[TBL] [Abstract][Full Text] [Related]
18. [The cost per year of life gained: trends and internal contradictions].
van Dam J
Ned Tijdschr Geneeskd; 2007 Feb; 151(7):441; author reply 441-2. PubMed ID: 17343145
[No Abstract] [Full Text] [Related]
19. Linking Costs and Survival in the Treatment of Older Adults With Chronic Myeloid Leukemia: An Analysis of SEER-Medicare Data From 1995 to 2007.
Lin PJ; Winn AN; Parsons SK; Neumann PJ; Weiss ES; Cohen JT
Med Care; 2016 Apr; 54(4):380-5. PubMed ID: 26759984
[TBL] [Abstract][Full Text] [Related]
20. Ground Hog Day.
Ansel GM
Catheter Cardiovasc Interv; 2007 Jul; 70(1):155. PubMed ID: 17585393
[No Abstract] [Full Text] [Related]
[Next] [New Search]
